related documents
- A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism. Conferences
- Adherence profile of etidronate (ETD), alendronate (ALD) and hormone replacement therapy (HRT) in patients registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO). Conferences
- Bone mineral density at the hip and tibia and speed of sound at the tibia in spinal cord injured individuals. Conferences
- CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up Conferences
- Calcitriol regulates the expression of genes encoding all three vitamin D3-hydroxylases in the human fetal intestine. Conferences
- Prevalence and severity of vertebral fractures among patients with chronic obstructive pulmonary disease (COPD) in Canada. Conferences
- Relation between disease activity and apparent trabecular texture at the wrist in individuals with rheumatoid arthritis. Conferences
- Risedronate conserves periarticular bone and ligament mechanical properties in early osteoarthritis. Conferences
- Secondary causes of osteoporosis in patients registered in the Canadian database of osteoporosis and osteopenia (CANDOO). Conferences
- The impact of dropouts on the efficacy of 5 mg risedronate: An assessment based on an imputation analysis Conferences
- The influence of bone mineral density (BMD) testing on the treatment of osteoporosis (OP) in two Canadian non-academic community centres. Conferences
- The relationship between prospective height loss and multiple vertebral fractures. Conferences
- The utility of prospective height loss for detecting vertebral fracture depends on fracture incidence Conferences